Apr 13, 2016
1447 Views

Dr Lal PathLabs Presents First Trimester Screening Test# for Screening Prenatal Disorders (Trisomy 21, 18 & 13)

SM95416FIRST TRIMESTER SCREENING, FMF Test#

First trimester screen is done on Fetal Medicine Foundation, UK, accredited platform for screening Prenatal disorders (trisomy 21, 18, & 13) to identify those women who are at sufficient risk for a congenital anomaly in the fetus to warrant further evaluation & follow up. The risk is calculated using SsDwLab6 software.

Advantages of FIRST TRIMESTER SCREENING, FMF Test#

  • Detection rate is high
  • If the observed risk is low, the patient can be put at ease early in her pregnancy
  • In the event of high risk, more time is available to decide on the diagnostic possibilities
  • Should the patient decide to terminate, procedure is safer when performed in early pregnancy

Added advantages of SsdwLab6 software

  • Type of twinning (Monochorionic & dichorionic twins): The software uses chorionicity-specific medians for calculating MoM [Generation of chorionicity-specific medians* for the biochemical markers and their use in risk assessment improves the performance of first trimester screening for chromosomal abnormalities in twins to a level comparable with that in singleton pregnancies]
  • Fetal dichotomous markers [Short femur, pyelectasis, echogenic cardiac foci, echogenic bowel, ventriculomegaly, abnormal ductal flow, Tricuspid regurgitation, single choroid plexus cyst, single umbilical artery] can be included for risk calculation

*Reference – Ultrasound Obstet Gynecol 2011;37, 38-474

#Kit is approved by FMF

Dr Lal PathLabs Presents First Trimester Screening Test# for Screening Prenatal Disorders (Trisomy 21, 18 & 13) was last modified: by

Article Categories:
For Doctors

Leave a Comment